Word

SYNVANT

Status

Dead

Status Code

606

Status Date

Monday, January 22, 2024

Serial Number

97222990

Mark Type

4000

Filing Date

Monday, January 17, 2022

Published for Opposition

Tuesday, April 25, 2023

Abandoned Date

Monday, January 22, 2024

Trademark Owner History

Syngene International Limited - Owner At Publication

Classifications

5 Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; biopharmaceuticals for the treatment of cancer; protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical diagnostic use; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma, diabetes, multiple sclerosis, acne; chemical preparations for use in DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes

16 Paper and cardboard; printed matter, namely, catalogs and brochures in the field of biotechnology; Bookbinding materials for creating hardcover books, namely, book covers, crackand-peel binding paper, reinforcement strips, peel-and-stick labels, stapler and staples; printed photographs; Plastic sheets, films and bags for wrapping and packaging; Plastic film for packaging; paper tags; paper bags for packaging; printed business cards; Bags of paper or plastics for packaging; printed vouchers

35 Maintaining patient medical records and files; Advertising research; Business research services; Market analysis and research services; Compilation of statistical data relating to medical research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare

1 Biotechnological products and preparations for laboratory use, namely, enzymes, proteins, carbohydrates, lipids, nucleic acids, DNA, immunological re-agents, and organic intermediates being fine chemicals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne, meningitis, asthma; chemicals for industrial use; assays for research purposes; unprocessed chemical polymers; chemicals for use in biotechnological product development; cells for scientific, laboratory or medical research; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; proteins for use in recombinant DNA technology for laboratory use; chemicals being reference standards for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific research; assays for research purposes(duplicate entry); diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes

44 Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; pathology services for medical and medical diagnostic purposes; medical testing services

42 Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosis, cardiology, nephrology, endocrinology; chemical, biochemical, biological and bacteriological research and analysis; Research and development in the field of diagnostic preparations; Biomedical research services; Computer aided scientific research, testing and analysis services; in the fields of medicine and pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Scientific research and custom design of pharmaceuticals; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; research and development services in the field of antibodies, antibody technology; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; DNA analysis services for scientific research purposes; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; scientific and medical laboratory services; services of a chemical and biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry

Trademark Events

Jan 22, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 22, 2024

Abandonment - No Use Statement Filed

Jun 20, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 25, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 25, 2023

Published For Opposition

Apr 5, 2023

Notification Of Notice Of Publication E-Mailed

Mar 22, 2023

Approved For Pub - Principal Register

Mar 22, 2023

Examiner's Amendment Entered

Mar 22, 2023

Notification Of Examiners Amendment E-Mailed

Mar 22, 2023

Examiners Amendment E-Mailed

Mar 22, 2023

Examiners Amendment -Written

Mar 9, 2023

Teas/Email Correspondence Entered

Mar 9, 2023

Correspondence Received In Law Office

Mar 9, 2023

Teas Response To Office Action Received

Dec 12, 2022

Notification Of Non-Final Action E-Mailed

Dec 12, 2022

Non-Final Action E-Mailed

Dec 12, 2022

Non-Final Action Written

Nov 1, 2022

Notification Of Priority Action E-Mailed

Nov 1, 2022

Priority Action E-Mailed

Nov 1, 2022

Priority Action Written

Oct 25, 2022

Assigned To Examiner

Jan 25, 2022

Teas Amendment Entered Before Attorney Assigned

Jan 25, 2022

Teas Voluntary Amendment Received

Jan 24, 2022

New Application Office Supplied Data Entered

Jan 20, 2022

New Application Entered